Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2009 (2009), Article ID 912320, 7 pages
http://dx.doi.org/10.1155/2009/912320
Research Article

Effects of Cytochrome P450 Inhibitors on Itraconazole and Fluconazole Induced Cytotoxicity in Hepatocytes

1Pharmacology and Toxicology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Putra Malaysia (UPM), Serdang, 43400 Selangor, Malaysia
2Faculty of Pharmacy, MARA University of Technology, 40500 Shah Alam, Malaysia

Received 10 November 2008; Accepted 16 May 2009

Academic Editor: Peter O'Brien

Copyright © 2009 Nhareet Somchit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Terrell, “Antifimgal agents—part II: the azoles,” Mayo Clinic Proceedings, vol. 74, no. 1, pp. 78–100, 1999. View at Google Scholar
  2. S. K. Gupta, N. Dhingra, T. Velpandian, and J. Jaiswal, “Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes,” Acta Ophthalmologica Scandinavica, vol. 78, no. 4, pp. 448–450, 2000. View at Publisher · View at Google Scholar
  3. P. A. Warn, J. Morrissey, C. B. Moore, and D. W. Denning, “In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 10, pp. 2664–2671, 2000. View at Publisher · View at Google Scholar
  4. A. Penk and L. Pittrow, “Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients,” Mycoses, vol. 42, no. 2, pp. 97–100, 1999. View at Google Scholar
  5. J. L. Harousseau, A. W. Dekker, A. Stamatoullas-Bastard et al., “Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 7, pp. 1887–1893, 2000. View at Publisher · View at Google Scholar
  6. D. S. Burgess and R. W. Hastings, “A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology,” Diagnostic Microbiology and Infectious Disease, vol. 38, no. 2, pp. 87–93, 2000. View at Publisher · View at Google Scholar
  7. M. S. Saag and W. E. Dismukes, “Azole antifungal agents: emphasis on new triazoles,” Antimicrobial Agents and Chemotherapy, vol. 32, no. 1, pp. 1–8, 1988. View at Google Scholar
  8. R. M. Tucker, Y. Haq, D. W. Denning, and D. A. Stevens, “Adverse events associated with itraconazole in 189 patients on chronic therapy,” Journal of Antimicrobial Chemotherapy, vol. 26, no. 4, pp. 561–566, 1990. View at Google Scholar
  9. R. J. Rodriguez and D. Acosta Jr., “N-deacetyl ketoconazole induced hepatoxicity in a primary culture system of rat hepatocytes,” Toxicology, vol. 117, pp. 123–131, 1997. View at Google Scholar
  10. R. J. Rodriquez, P. J. Proteau, B. L. Marquez, C. L. Hetherington, and D. Acosta Jr., “Flavin-ontaining monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes,” Drug Metabolism Disposition, vol. 27, pp. 880–886, 1999. View at Google Scholar
  11. J. Miquel, A. Bernd, J. Sempere, J. Díaz-Alperi, and A. Ramírez, “The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review,” Archives of Gerontology and Geriatrics, vol. 34, no. 1, pp. 37–46, 2002. View at Publisher · View at Google Scholar
  12. R. S. Ramsewak, D. L. DeWitt, and M. G. Nair, “Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa,” Phytomedicine, vol. 7, no. 4, pp. 303–308, 2000. View at Google Scholar
  13. J. T. Piper, S. S. Singhal, M. S. Salameh, R. T. Torman, Y. C. Awasthi, and S. Awasthi, “Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver,” International Journal of Biochemistry and Cell Biology, vol. 30, no. 4, pp. 445–456, 1998. View at Publisher · View at Google Scholar
  14. R. Thapliyal and G. B. Maru, “Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo,” Food and Chemical Toxicology, vol. 39, no. 6, pp. 541–547, 2001. View at Publisher · View at Google Scholar
  15. N. Somchit, S. M. Hassim, and S. H. Samsudin, “Itraconazole- and fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study,” Human and Experimental Toxicology, vol. 21, no. 1, pp. 43–48, 2002. View at Publisher · View at Google Scholar
  16. N. Somchit, A. R. Norshahida, A. H. Hasiah, A. Zuraini, M. R. Sulaiman, and M. M. Noordin, “Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study,” Human and Experimental Toxicology, vol. 23, no. 11, pp. 519–525, 2004. View at Publisher · View at Google Scholar
  17. N. Somchit, C. W. Wong, A. Zuraini et al., “Involvement of phenobarbital and SKF 525A in the hepatotoxicity of antifungal drugs itraconazole and fluconazole in rats,” Drug and Chemical Toxicology, vol. 29, no. 3, pp. 237–253, 2006. View at Publisher · View at Google Scholar
  18. P. Moldéus, J. Högberg, and S. Orrenius, “Isolation and use of liver cells,” Methods in Enzymology, vol. 52, pp. 60–71, 1978. View at Google Scholar
  19. N. J. Swales, C. Luong, and J. Caldwell, “Cryopreservation of rat and mouse hepatocytes: I. Comparative viability studies,” Drug Metabolism and Disposition, vol. 24, no. 11, pp. 1218–1223, 1996. View at Google Scholar
  20. A. D. Marshall and J. Caldwell, “Influence of modulators of epoxide metabolism on the cytotoxicity of trans-anethole in freshly isolated rat hepatocytes,” Food and Chemical Toxicology, vol. 30, no. 6, pp. 467–473, 1992. View at Publisher · View at Google Scholar
  21. T. Qian, A.-L. Nieminen, B. Herman, and J. J. Lemasters, “Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes,” American Journal of Physiology, vol. 273, no. 6, pp. C1783–C1792, 1997. View at Google Scholar
  22. M. Jurima-Romet, K. Crawford, T. Cyr, and T. Inaba, “Terfenadine metabolism in human liver: in vitro inhibition by macrolide antibiotics and azole antifungals,” Drug Metabolism and Disposition, vol. 22, no. 6, pp. 849–857, 1994. View at Google Scholar
  23. L. A. Jeu, F. J. Piacenti, A. G. Lyakhovetskiy, and H. B. Fung, “Voriconazole,” Clinical Therapeutics, vol. 25, pp. 1321–1381, 2003. View at Google Scholar
  24. N. Isoherranen, K. L. Kunze, K. E. Allen, W. L. Nelson, and K. E. Thummel, “Role of itraconazole metabolites in CYP3A4 inhibition,” Drug Metabolism and Disposition, vol. 32, no. 10, pp. 1121–1131, 2004. View at Publisher · View at Google Scholar
  25. D. J. Back and J. F. Tjia, “Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes,” British Journal of Clinical Pharmacology, vol. 32, no. 5, pp. 624–626, 1991. View at Google Scholar
  26. S. M. Grant and S. P. Clissold, “Fluconazole. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential in superficial and systematic,” Mycoses, vol. 39, pp. 877–916, 1990. View at Google Scholar
  27. K. Lavrijsen, J. van Houdt, D. M. van Dyck, W. Meuldermans, and J. Heykants, “Induction potential of fluconazole towards drug-metabolising enzymes in rats,” Antimicrobial Agents and Chemotherapy, vol. 34, pp. 402–408, 1990. View at Google Scholar
  28. A. R. Goeptar, E. J. Groot, H. Scheerens, J. N. M. Commandeur, and N. P. E. Vermeulen, “Cytotoxicity of mitomycin C and Adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450,” Cancer Research, vol. 54, no. 9, pp. 2411–2418, 1994. View at Google Scholar
  29. A. P. Lavrijsen, K. J. Balmus, W. M. Nugteren-Huying, A. C. Roldaan, J. W. van Wout, and B. H. Stricker, “Liver damage during administration of itraconazole (Trisporal),” Nederlands Tijdschrift Geneeskunde, vol. 137, no. 1, pp. 38–41, 1993. View at Google Scholar